Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

0.7101
Delayed Data
As of Oct 20
 -0.0297 / -4.01%
Today’s Change
0.43
Today|||52-Week Range
4.50
-78.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.00314.2K1.3M148.1K
 
 
 
 
Depreciation And Amortization0.0012.2K21.4K96.6K
 
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses5.8M8.7M19.4M16.7M
 
 
 
 
 
Research And Development2.0M3.5M9.6M7.8M
 
 
 
 
 
Total Operating Expenses5.8M8.7M19.4M16.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-8.4M-18.1M-16.7M
 
 
 
 
 
Extraordinary Credit591.0K475.4K19.8K0.00
 
 
 
 
Interest Expense On Debt--0.000.00997.4K
 
 
Other Expenses8.0K-379.00-227.000.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.2M-7.9M-18.1M-17.7M
 
 
 
 
 
Preferred Dividend0.00-2.7M-17.9M0.00
 
 
 
Net Income-5.2M-7.9M-18.1M-17.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.7K150.3K2.7M24.2M
 
 
 
 
 
Shares To Calculate EPS Diluted75.7K150.3K2.7M24.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$69.26-$70.37-$13.47-$3.64
 
 
 
 
 
EPS Diluted-$69.26-$70.37-$13.47-$0.73